The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity

Breast cancer is the most common malignancy in women worldwide and it remains a global health burden, in part, due to poor response and tolerance to current therapeutics. Drug repurposing, which seeks to identify new indications for existing and investigational drugs, has become an exciting strategy...

Descripción completa

Detalles Bibliográficos
Autores principales: Neumann-Mufweba, Alexis, Kimani, Serah, Khan, Saif Feroz, Chibale, Kelly, Prince, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149975/
https://www.ncbi.nlm.nih.gov/pubmed/35651652
http://dx.doi.org/10.17179/excli2021-4323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149975/
https://www.ncbi.nlm.nih.gov/pubmed/35651652
http://dx.doi.org/10.17179/excli2021-4323

Ejemplares similares